These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12200396)

  • 1. Rituximab treatment of refractory fludarabine-associated immune thrombocytopenia in chronic lymphocytic leukemia.
    Hegde UP; Wilson WH; White T; Cheson BD
    Blood; 2002 Sep; 100(6):2260-2. PubMed ID: 12200396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic thrombocytopenic purpura and myasthenia gravis after fludarabine treatment for chronic lymphocytic leukemia.
    Fujimaki K; Takasaki H; Koharazawa H; Takabayashi M; Yamaji S; Baba Y; Kanamori H; Ishigatsubo Y
    Leuk Lymphoma; 2005 Jul; 46(7):1101-2. PubMed ID: 16019566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune thrombocytopenia due to chronic lymphocytic leukemia treated with fludarabine.
    Wells T; Kovacs MJ
    Ann Pharmacother; 2003 May; 37(5):671-4. PubMed ID: 12708944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune thrombocytopenia induced by fludarabine successfully treated with rituximab.
    Fernandez MJ; Llopis I; Pastor E; Real E; Grau E
    Haematologica; 2003 Feb; 88(2):ELT02. PubMed ID: 12604433
    [No Abstract]   [Full Text] [Related]  

  • 5. Fludarabine induced immune thrombocytopenia in a patient with CD5 positive B cell chronic lymphocytic leukemia.
    Usman M; Adil SN; Sajid R; Khurshid M
    J Pak Med Assoc; 2003 Oct; 53(10):496-7. PubMed ID: 14696895
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia.
    Schulz H; Klein SK; Rehwald U; Reiser M; Hinke A; Knauf WU; Aulitzky WE; Hensel M; Herold M; Huhn D; Hallek M; Diehl V; Engert A;
    Blood; 2002 Nov; 100(9):3115-20. PubMed ID: 12384407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab is effective for selected patients with chronic steroid-refractory immune thrombocytopenic purpura.
    Lalayanni C; Stavroyianni N; Saloum R; Tsompanakou A; Anagnostopoulos A
    Hematology; 2004 Aug; 9(4):287-9. PubMed ID: 15621736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune thrombocytopenia: a complication of fludarabine therapy in lymphoproliferative disorders.
    Leach M; Parsons RM; Reilly JT; Winfield DA
    Clin Lab Haematol; 2000 Jun; 22(3):175-8. PubMed ID: 10931169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
    Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
    Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of chronic lymphocytic leukemia with regimen of fludarabine, cyclophosphamide and rituximab].
    Gu WJ; Xu W; Qian SX; Wu YJ; Hong M; Chen LJ; Wu HX; Lu H; Qiu HX; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):938-42. PubMed ID: 18718095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combination of rituximab, cyclophosphamide and dexamethasone effectively treats immune cytopenias of chronic lymphocytic leukemia.
    Kaufman M; Limaye SA; Driscoll N; Johnson C; Caramanica A; Lebowicz Y; Patel D; Kohn N; Rai K
    Leuk Lymphoma; 2009 Jun; 50(6):892-9. PubMed ID: 19391041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
    Robak T; Lech-Maranda E; Robak P
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
    Nishida H; Murase T; Ueno H; Park JW; Yano T; Ikeda Y
    Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment options for chronic refractory idiopathic thrombocytopenic purpura in adults: focus on romiplostim and eltrombopag.
    Chouhan JD; Herrington JD
    Pharmacotherapy; 2010 Jul; 30(7):666-83. PubMed ID: 20575632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Successful combined treatment with rituximab and high dose immunoglobulin in a patient with chronic lymphocytic leukemia with fludarabine-induced severe immune thrombocytopenia].
    Telek B; Batár P; Uvardy M
    Orv Hetil; 2005 Aug; 146(34):1791-3. PubMed ID: 16184881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic lymphocytic leukemia-associated refractory immune thrombocytopenia successfully treated with eltrombopag.
    Chang H; Shih LY
    Tumori; 2015 Apr; 101(2):e49-50. PubMed ID: 25702666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing the action of rituximab by adding fresh frozen plasma for the treatment of fludarabine refractory chronic lymphocytic leukemia.
    Xu W; Miao KR; Zhu DX; Fang C; Zhu HY; Dong HJ; Wang DM; Wu YJ; Qiao C; Li JY
    Int J Cancer; 2011 May; 128(9):2192-201. PubMed ID: 20635386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia.
    Castro JE; Sandoval-Sus JD; Bole J; Rassenti L; Kipps TJ
    Leukemia; 2008 Nov; 22(11):2048-53. PubMed ID: 18754025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of rituximab in patients with splenectomized refractory chronic idiopathic thrombocythopenic purpura.
    Pasa S; Altintas A; Cil T; Danis R; Ayyildiz O
    J Thromb Thrombolysis; 2009 Apr; 27(3):329-33. PubMed ID: 18311541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.
    Stasi R; Pagano A; Stipa E; Amadori S
    Blood; 2001 Aug; 98(4):952-7. PubMed ID: 11493438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.